Bio
Janet M. Sasso es licenciada en Biología por la Ohio State University (OSU). También cuenta con un máster en Salud Pública por la OSU, donde centró su investigación en la equidad y la educación en materia de salud pública. Se incorporó a CAS en 2006 como científica de la información en el departamento de Ciencias Biológicas, donde se encarga de la información sobre investigación farmacológica, farmacéutica, medioambiental y toxicológica. Le apasiona la comunicación científica para acelerar el análisis científico e inspirar el avance en todo el mundo.
Ciencia emergente
Nipah virus explained: Risks, realities, and the hope from new research
New Nipah cases in India have renewed focus on a high‑fatality zoonotic threat shaped by complex spillover dynamics, severe neurological disease, and limited medical countermeasures. Meanwhile, global efforts in diagonistcs, therapeutics, and vaccines are accelerating.
Ciencia emergente
Mejorar la salud animal con terapias del microbioma intestinal
Sabemos que el microbioma intestinal es vital para la salud humana, y ahora los nuevos descubrimientos reducen la resistencia a los antibióticos y mejoran la salud general de los animales.
Seguridad
Seminario web: Investigación, definiciones y novedades normativas sobre los PFAS
Desde los productos farmacéuticos hasta los semiconductores, los compuestos PFAS están en todas partes. Este resumen del seminario web de ACS/CAS explora cómo las definiciones estructurales en evolución cambian el panorama normativo y lo que significa para la ciencia, la política y la innovación.
Ciencia emergente
El futuro de la administración de fármacos basada en lípidos
Resumen del seminario web sobre el panorama de la administración de fármacos basada en lípidos
Ciencia emergente
Seminario web: tendencias en ciencia de materiales que hay que observar en 2025
Escuche lo que dicen los principales expertos sobre las tendencias de la ciencia de los materiales para 2025
Ciencia emergente
Seminario web: Descubrimientos científicos y tendencias emergentes de interés para 2025
Escuche la opinión de diversos expertos sobre las tendencias científicas que hay que observar en 2025.
Ciencia emergente
Healthy longevity: Aging hallmarks and strategies
Experts from CAS, Harvard Medical School, Procter & Gamble, and Cedars-Sinai Medical Center discuss health aging research.
Ciencia emergente
Latest developments in the global mpox outbreak
With recent headlines on monkeypox, learn more about the research landscape, scientific profiles, and currently available therapies. A deeper understanding of the published science enables clarity and insight on this emerging news story.
Materiales
Webinar: Emerging areas in biomaterials - Reshaping medicine and human health
Biomaterials are making an impact on health and medicine. Experts from CAS, Ortholevo, and Westlake University discuss the full landscape.
Drug Discovery
Enfermedades raras y enfermedades huérfanas: ¿pueden tratarse las terapias combinadas?
Cómo las terapias combinadas, como la reutilización de fármacos, la terapia celular y la terapia génica, están mejorando el tratamiento de las enfermedades raras.
Ciencia emergente
Decoding neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's
Uncover the latest advancements in understanding and treating neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Huntington’s.
Ciencia emergente
Webinar: Scientific breakthroughs and emerging trends to watch in 2024
Experts from Lawrence Livermore National Lab, Oak Ridge National Lab, The Ohio State University, and CAS discuss major research trends in 2024.
Ciencia emergente
Biomarkers: The key to earlier cancer detection and patient outcomes
CAS and Excelra delved into data surrounding biomarkers and their relationship to cancer to identify key targets for future study.
Biotechnology
How biomarkers unlock faster cancer detection, improving outcomes
As cancer is projected to increase, finding stronger therapeutics is more urgent. Biomarkers offer a potential solution for better diagnosis and treatment.
Drug Discovery
Unveiling the potential of the antibody drug conjugate
Since 2018, research interest in antibody-drug conjugates has increased exponentially, due to their potential in the fight against cancer.
Ciencia emergente
Webinar on gut microbiome-brain alliance: The connection to health and disorders
CAS, Bayer, and Caltech explore how the gut-brain axis influences health from IBS to autism.
Ciencia emergente
Aging reimagined: Exploring the potential of anti-aging treatment strategies
Discover the latest in anti-aging treatment strategies to promote health and longevity, including stem cell therapies, hyaluronic acid, senolytics, gene therapy, and more.
Biotechnology
Webinar on nature’s lipid nanoparticles: Exosomes
Exosomes have enormous potential in drug delivery, diagnostics, and more. Mayo Clinic, Direct Biologics, and Aruna Bio discuss the full landscape.
Drug Discovery
Exosome research: from platelet dust to pioneering therapeutics
Landscape view of emerging contributors, companies, and researchers in the emerging field of exosome research. This article overviews key players in diagnostics and therapeutic fields of exosome research with a deeper look into the current clinical pipeline.
Drug Discovery
ACS webinar on molecular glues and targeted protein degradation
Expert panelists include Dr. Benjamin Ebert, the chair of Medical Oncology at the Dana-Farber Institute, Dr. Phil Chamberlain, the co-founder, President, and CEO of Neomorph, and Janet Sasso, an information scientist specializing in Life Sciences at CAS.
Drug Discovery
Why the omicron BA.5 variant evades vaccines
As COVID-19 cases rise again worldwide, the Omicron subvariant BA.5 is currently the dominant strain. This blog explores some key mutations that increase transmission, evade protective antibodies, and increase the rate of (re)infection.
Biotechnology
Molecular glues tackle undruggable targets
Molecular glues have been used to uncover new therapeutic agents. Because of their targeted protein degradation that holds them together, these glues have exciting potential in uncovering new drugs to fight cancer, immune diseases, and more.
Biotechnology
A therapeutic revolution: RNA in COVID-19 and beyond
We are in the midst of a therapeutic revolution, according to the authors of a recent review article in Frontiers in Bioengineering and Biotechnology.
Biotechnology
COVID-19 vaccine boosters: what does the research show?
With recent mRNA booster recommendations, many ask if they should get a COVID-19 booster and what the science shows? This blog explains the science of boosters, reviews current recommendations, and examines recent research.